Therapeutic Classes/Nonsteroidal Mineralocorticoid-Receptor Antagonist

Nonsteroidal Mineralocorticoid-Receptor Antagonist

9 drugs across 1 manufacturer|0 Generic,9 Brand

The Nonsteroidal Mineralocorticoid-Receptor Antagonist class contains 9 NDCs from 1 manufacturer (0 generic, 9 brand), at an average NADAC of $22.86 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

9

0G / 9B

Manufacturers

1

Avg $22.8571/unit

Avg 7d Change

-0.05%

Across 9 drugs with changes

7d Activity

6↑3↓0 flat

of 9 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

1 manufacturer producing drugs in this therapeutic class

Drug Portfolio

9 drugs total, 9 shown

Drug ↕Price 7d Change ↕
KERENDIA 40 MG TABLET
finerenone
$22.8643
per EA
-0.14%
KERENDIA 40 MG TABLET
finerenone
$22.8643
per EA
-0.14%
KERENDIA 40 MG TABLET
finerenone
$22.8643
per EA
-0.14%
KERENDIA 10 MG TABLET
finerenone
$22.8555
per EA
+0.04%
KERENDIA 10 MG TABLET
finerenone
$22.8555
per EA
+0.04%
KERENDIA 10 MG TABLET
finerenone
$22.8555
per EA
+0.04%
KERENDIA 20 MG TABLET
finerenone
$22.8515
per EA
+0.04%
KERENDIA 20 MG TABLET
finerenone
$22.8515
per EA
+0.04%
KERENDIA 20 MG TABLET
finerenone
$22.8515
per EA
+0.04%

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Frequently Asked Questions

How many drugs are in the Nonsteroidal Mineralocorticoid-Receptor Antagonist class?

The Nonsteroidal Mineralocorticoid-Receptor Antagonist class contains 9 NDCs from 1 manufacturer — 0 generic and 9 brand products.

What is the average price of Nonsteroidal Mineralocorticoid-Receptor Antagonist drugs?

The average NADAC for the Nonsteroidal Mineralocorticoid-Receptor Antagonist class is $22.8571 per unit across 9 NDCs.

Which manufacturers make Nonsteroidal Mineralocorticoid-Receptor Antagonist drugs?

1 manufacturer makes drugs in the Nonsteroidal Mineralocorticoid-Receptor Antagonist class. Ranked by number of NDCs, the largest are Bayer HealthCare Pharmaceuticals Inc. (9).

How has Nonsteroidal Mineralocorticoid-Receptor Antagonist pricing changed recently?

Over the past 7 days, 6 NDCs in this class rose and 3 fell, with a class-wide average change of -0.1%.